IBDEI0A4 ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13421,0)
 ;;=99231^^87^791^1
 ;;^UTILITY(U,$J,358.3,13421,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13421,1,1,0)
 ;;=1^Problem Focused Exam
 ;;^UTILITY(U,$J,358.3,13421,1,2,0)
 ;;=2^99231
 ;;^UTILITY(U,$J,358.3,13422,0)
 ;;=99232^^87^791^2
 ;;^UTILITY(U,$J,358.3,13422,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13422,1,1,0)
 ;;=1^Exp Problem Focused Exam
 ;;^UTILITY(U,$J,358.3,13422,1,2,0)
 ;;=2^99232
 ;;^UTILITY(U,$J,358.3,13423,0)
 ;;=99233^^87^791^3
 ;;^UTILITY(U,$J,358.3,13423,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13423,1,1,0)
 ;;=1^Detailed Exam
 ;;^UTILITY(U,$J,358.3,13423,1,2,0)
 ;;=2^99233
 ;;^UTILITY(U,$J,358.3,13424,0)
 ;;=99238^^87^792^1
 ;;^UTILITY(U,$J,358.3,13424,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13424,1,1,0)
 ;;=1^D/C Visit incl Pronouncement of Death < 31min
 ;;^UTILITY(U,$J,358.3,13424,1,2,0)
 ;;=2^99238
 ;;^UTILITY(U,$J,358.3,13425,0)
 ;;=99239^^87^792^2
 ;;^UTILITY(U,$J,358.3,13425,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13425,1,1,0)
 ;;=1^D/C Visit incl Pronouncement of Death > 30min
 ;;^UTILITY(U,$J,358.3,13425,1,2,0)
 ;;=2^99239
 ;;^UTILITY(U,$J,358.3,13426,0)
 ;;=188.9^^88^793^5
 ;;^UTILITY(U,$J,358.3,13426,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13426,1,1,0)
 ;;=1^188.9
 ;;^UTILITY(U,$J,358.3,13426,1,2,0)
 ;;=2^BLADDER CANCER
 ;;^UTILITY(U,$J,358.3,13426,2)
 ;;=^267253
 ;;^UTILITY(U,$J,358.3,13427,0)
 ;;=162.9^^88^793^25
 ;;^UTILITY(U,$J,358.3,13427,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13427,1,1,0)
 ;;=1^162.9
 ;;^UTILITY(U,$J,358.3,13427,1,2,0)
 ;;=2^LUNG CANCER
 ;;^UTILITY(U,$J,358.3,13427,2)
 ;;=^73521
 ;;^UTILITY(U,$J,358.3,13428,0)
 ;;=191.9^^88^793^7
 ;;^UTILITY(U,$J,358.3,13428,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13428,1,1,0)
 ;;=1^191.9
 ;;^UTILITY(U,$J,358.3,13428,1,2,0)
 ;;=2^BRAIN CANCER
 ;;^UTILITY(U,$J,358.3,13428,2)
 ;;=^267279
 ;;^UTILITY(U,$J,358.3,13429,0)
 ;;=171.9^^88^793^50
 ;;^UTILITY(U,$J,358.3,13429,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13429,1,1,0)
 ;;=1^171.9
 ;;^UTILITY(U,$J,358.3,13429,1,2,0)
 ;;=2^SARCOMAS/OTH SOFT TISSUE CANCER
 ;;^UTILITY(U,$J,358.3,13429,2)
 ;;=^267165
 ;;^UTILITY(U,$J,358.3,13430,0)
 ;;=150.9^^88^793^16
 ;;^UTILITY(U,$J,358.3,13430,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13430,1,1,0)
 ;;=1^150.9
 ;;^UTILITY(U,$J,358.3,13430,1,2,0)
 ;;=2^ESOPHAGEAL CANCER
 ;;^UTILITY(U,$J,358.3,13430,2)
 ;;=^267055
 ;;^UTILITY(U,$J,358.3,13431,0)
 ;;=153.9^^88^793^15
 ;;^UTILITY(U,$J,358.3,13431,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13431,1,1,0)
 ;;=1^153.9
 ;;^UTILITY(U,$J,358.3,13431,1,2,0)
 ;;=2^COLON CANCER
 ;;^UTILITY(U,$J,358.3,13431,2)
 ;;=^267078
 ;;^UTILITY(U,$J,358.3,13432,0)
 ;;=152.9^^88^793^55
 ;;^UTILITY(U,$J,358.3,13432,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13432,1,1,0)
 ;;=1^152.9
 ;;^UTILITY(U,$J,358.3,13432,1,2,0)
 ;;=2^SMALL INTESTINE CANCER
 ;;^UTILITY(U,$J,358.3,13432,2)
 ;;=^267077
 ;;^UTILITY(U,$J,358.3,13433,0)
 ;;=193.^^88^793^60
 ;;^UTILITY(U,$J,358.3,13433,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13433,1,1,0)
 ;;=1^193.
 ;;^UTILITY(U,$J,358.3,13433,1,2,0)
 ;;=2^THYROID CANCER
 ;;^UTILITY(U,$J,358.3,13433,2)
 ;;=^267296
 ;;^UTILITY(U,$J,358.3,13434,0)
 ;;=284.9^^88^793^3
 ;;^UTILITY(U,$J,358.3,13434,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13434,1,1,0)
 ;;=1^284.9
 ;;^UTILITY(U,$J,358.3,13434,1,2,0)
 ;;=2^APLASTIC ANEMIA NOS
 ;;^UTILITY(U,$J,358.3,13434,2)
 ;;=^7020
 ;;^UTILITY(U,$J,358.3,13435,0)
 ;;=170.9^^88^793^6
 ;;^UTILITY(U,$J,358.3,13435,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13435,1,1,0)
 ;;=1^170.9
 ;;^UTILITY(U,$J,358.3,13435,1,2,0)
 ;;=2^BONE AND CARTILAGE CANCER
 ;;^UTILITY(U,$J,358.3,13435,2)
 ;;=^267155
 ;;^UTILITY(U,$J,358.3,13436,0)
 ;;=175.9^^88^793^9
 ;;^UTILITY(U,$J,358.3,13436,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13436,1,1,0)
 ;;=1^175.9
 ;;^UTILITY(U,$J,358.3,13436,1,2,0)
 ;;=2^BREAST CANCER-MALE
 ;;^UTILITY(U,$J,358.3,13436,2)
 ;;=^267205
 ;;^UTILITY(U,$J,358.3,13437,0)
 ;;=209.10^^88^793^10
 ;;^UTILITY(U,$J,358.3,13437,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13437,1,1,0)
 ;;=1^209.10
 ;;^UTILITY(U,$J,358.3,13437,1,2,0)
 ;;=2^CARCINOID, LARGE INTESTINE
 ;;^UTILITY(U,$J,358.3,13437,2)
 ;;=^336722
 ;;^UTILITY(U,$J,358.3,13438,0)
 ;;=209.29^^88^793^11
 ;;^UTILITY(U,$J,358.3,13438,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13438,1,1,0)
 ;;=1^209.29
 ;;^UTILITY(U,$J,358.3,13438,1,2,0)
 ;;=2^CARCINOID,NONBOWEL AND OTH SITE
 ;;^UTILITY(U,$J,358.3,13438,2)
 ;;=^336507
 ;;^UTILITY(U,$J,358.3,13439,0)
 ;;=209.00^^88^793^12
 ;;^UTILITY(U,$J,358.3,13439,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13439,1,1,0)
 ;;=1^209.00
 ;;^UTILITY(U,$J,358.3,13439,1,2,0)
 ;;=2^CARCINOID,SMALL INTESTINE
 ;;^UTILITY(U,$J,358.3,13439,2)
 ;;=^336721
 ;;^UTILITY(U,$J,358.3,13440,0)
 ;;=156.9^^88^793^13
 ;;^UTILITY(U,$J,358.3,13440,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13440,1,1,0)
 ;;=1^156.9
 ;;^UTILITY(U,$J,358.3,13440,1,2,0)
 ;;=2^CHOLANGIOCARCINOMA
 ;;^UTILITY(U,$J,358.3,13440,2)
 ;;=^267102
 ;;^UTILITY(U,$J,358.3,13441,0)
 ;;=286.9^^88^793^14
 ;;^UTILITY(U,$J,358.3,13441,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13441,1,1,0)
 ;;=1^286.9
 ;;^UTILITY(U,$J,358.3,13441,1,2,0)
 ;;=2^COAGULATION DEFECTS
 ;;^UTILITY(U,$J,358.3,13441,2)
 ;;=^87267
 ;;^UTILITY(U,$J,358.3,13442,0)
 ;;=156.9^^88^793^17
 ;;^UTILITY(U,$J,358.3,13442,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13442,1,1,0)
 ;;=1^156.9
 ;;^UTILITY(U,$J,358.3,13442,1,2,0)
 ;;=2^GALLBLADDER CANCER
 ;;^UTILITY(U,$J,358.3,13442,2)
 ;;=^267102
 ;;^UTILITY(U,$J,358.3,13443,0)
 ;;=459.0^^88^793^19
 ;;^UTILITY(U,$J,358.3,13443,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13443,1,1,0)
 ;;=1^459.0
 ;;^UTILITY(U,$J,358.3,13443,1,2,0)
 ;;=2^HEMORRHAGE NOS
 ;;^UTILITY(U,$J,358.3,13443,2)
 ;;=^55877
 ;;^UTILITY(U,$J,358.3,13444,0)
 ;;=176.9^^88^793^20
 ;;^UTILITY(U,$J,358.3,13444,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13444,1,1,0)
 ;;=1^176.9
 ;;^UTILITY(U,$J,358.3,13444,1,2,0)
 ;;=2^KAPOSI'S SARCOMA, NOS
 ;;^UTILITY(U,$J,358.3,13444,2)
 ;;=^107993
 ;;^UTILITY(U,$J,358.3,13445,0)
 ;;=161.9^^88^793^21
 ;;^UTILITY(U,$J,358.3,13445,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13445,1,1,0)
 ;;=1^161.9
 ;;^UTILITY(U,$J,358.3,13445,1,2,0)
 ;;=2^LARYNGEAL CANCER
 ;;^UTILITY(U,$J,358.3,13445,2)
 ;;=^267128
 ;;^UTILITY(U,$J,358.3,13446,0)
 ;;=208.90^^88^793^22
 ;;^UTILITY(U,$J,358.3,13446,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13446,1,1,0)
 ;;=1^208.90
 ;;^UTILITY(U,$J,358.3,13446,1,2,0)
 ;;=2^LEUKEMIA,UNSP CELL TYPE
 ;;^UTILITY(U,$J,358.3,13446,2)
 ;;=^336874
 ;;^UTILITY(U,$J,358.3,13447,0)
 ;;=140.9^^88^793^23
 ;;^UTILITY(U,$J,358.3,13447,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13447,1,1,0)
 ;;=1^140.9
 ;;^UTILITY(U,$J,358.3,13447,1,2,0)
 ;;=2^LIP CANCER
 ;;^UTILITY(U,$J,358.3,13447,2)
 ;;=^266994
 ;;^UTILITY(U,$J,358.3,13448,0)
 ;;=155.0^^88^793^24
 ;;^UTILITY(U,$J,358.3,13448,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13448,1,1,0)
 ;;=1^155.0
 ;;^UTILITY(U,$J,358.3,13448,1,2,0)
 ;;=2^LIVER CANCER
 ;;^UTILITY(U,$J,358.3,13448,2)
 ;;=^73526
 ;;^UTILITY(U,$J,358.3,13449,0)
 ;;=200.60^^88^793^26
 ;;^UTILITY(U,$J,358.3,13449,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13449,1,1,0)
 ;;=1^200.60
 ;;^UTILITY(U,$J,358.3,13449,1,2,0)
 ;;=2^LYMPHOMA,ANAPLASTIC LARGE CELL
 ;;^UTILITY(U,$J,358.3,13449,2)
 ;;=^335299
 ;;^UTILITY(U,$J,358.3,13450,0)
 ;;=200.20^^88^793^27
 ;;^UTILITY(U,$J,358.3,13450,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13450,1,1,0)
 ;;=1^200.20
 ;;^UTILITY(U,$J,358.3,13450,1,2,0)
 ;;=2^LYMPHOMA,BURKITT'S
 ;;^UTILITY(U,$J,358.3,13450,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,13451,0)
 ;;=201.90^^88^793^28
 ;;^UTILITY(U,$J,358.3,13451,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13451,1,1,0)
 ;;=1^201.90
 ;;^UTILITY(U,$J,358.3,13451,1,2,0)
 ;;=2^LYMPHOMA,HODGKIN'S
 ;;^UTILITY(U,$J,358.3,13451,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,13452,0)
 ;;=200.70^^88^793^29
 ;;^UTILITY(U,$J,358.3,13452,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13452,1,1,0)
 ;;=1^200.70
 ;;^UTILITY(U,$J,358.3,13452,1,2,0)
 ;;=2^LYMPHOMA,LARGE CELL
 ;;^UTILITY(U,$J,358.3,13452,2)
 ;;=^335300
 ;;^UTILITY(U,$J,358.3,13453,0)
 ;;=200.40^^88^793^30
 ;;^UTILITY(U,$J,358.3,13453,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13453,1,1,0)
 ;;=1^200.40
 ;;^UTILITY(U,$J,358.3,13453,1,2,0)
 ;;=2^LYMPHOMA,MANTLE CELL
 ;;^UTILITY(U,$J,358.3,13453,2)
 ;;=^335297
 ;;^UTILITY(U,$J,358.3,13454,0)
 ;;=200.30^^88^793^31
 ;;^UTILITY(U,$J,358.3,13454,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13454,1,1,0)
 ;;=1^200.30
 ;;^UTILITY(U,$J,358.3,13454,1,2,0)
 ;;=2^LYMPHOMA,MARGINAL ZONE
 ;;^UTILITY(U,$J,358.3,13454,2)
 ;;=^335296
 ;;^UTILITY(U,$J,358.3,13455,0)
 ;;=200.50^^88^793^33
 ;;^UTILITY(U,$J,358.3,13455,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13455,1,1,0)
 ;;=1^200.50
 ;;^UTILITY(U,$J,358.3,13455,1,2,0)
 ;;=2^LYMPHOMA,PRIM CTR NERVOUS SYS
 ;;^UTILITY(U,$J,358.3,13455,2)
 ;;=^335298
 ;;^UTILITY(U,$J,358.3,13456,0)
 ;;=202.90^^88^793^32
 ;;^UTILITY(U,$J,358.3,13456,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13456,1,1,0)
 ;;=1^202.90
 ;;^UTILITY(U,$J,358.3,13456,1,2,0)
 ;;=2^LYMPHOMA,OTHER SITE
 ;;^UTILITY(U,$J,358.3,13456,2)
 ;;=^267504
 ;;^UTILITY(U,$J,358.3,13457,0)
 ;;=200.10^^88^793^34
 ;;^UTILITY(U,$J,358.3,13457,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13457,1,1,0)
 ;;=1^200.10
 ;;^UTILITY(U,$J,358.3,13457,1,2,0)
 ;;=2^LYMPHOSARCOMA
 ;;^UTILITY(U,$J,358.3,13457,2)
 ;;=^175886
 ;;^UTILITY(U,$J,358.3,13458,0)
 ;;=172.9^^88^793^35
 ;;^UTILITY(U,$J,358.3,13458,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13458,1,1,0)
 ;;=1^172.9
 ;;^UTILITY(U,$J,358.3,13458,1,2,0)
 ;;=2^MALIGNANT MELANOMA
 ;;^UTILITY(U,$J,358.3,13458,2)
 ;;=^75462
 ;;^UTILITY(U,$J,358.3,13459,0)
 ;;=199.0^^88^793^37
 ;;^UTILITY(U,$J,358.3,13459,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13459,1,1,0)
 ;;=1^199.0
